Kaplan, M. A. Et Al. 2019. The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.24, no.3 , 1081-1086.

Kaplan, M. A., Oruc, Z., Gumus, M., Ozaydm, S., ELKIRAN, E. T., Dine, N. S., ... Sakin, A.(2019). The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.24, no.3, 1081-1086.

Kaplan, Muhammet Et Al. "The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study," JOURNAL OF BUON , vol.24, no.3, 1081-1086, 2019

Kaplan, Muhammet A. Et Al. "The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.24, no.3, pp.1081-1086, 2019

Kaplan, M. A. Et Al. (2019) . "The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.24, no.3, pp.1081-1086.

@article{article, author={Muhammet Ali Kaplan Et Al. }, title={The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study}, journal={JOURNAL OF BUON}, year=2019, pages={1081-1086} }